Abstract:The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway is an evolving DNA-sensing mechanism involved in innate immunity and pathogen defense that has been optimized while remaining conserved. Aside from recognizing pathogens through conserved motifs, these receptors also detect aberrant or misplaced self-molecules as possible signs of perturbed homeostasis. Upon binding external or self-derived DNA, a mobile secondary messenger 2′3′-cyclic GMP-AMP (cGAMP) is produced by cGAS and in turn activates its adapter STING in the endoplasmic reticulum (ER). Resting-state or activated STING protein is finely restricted by multiple degradation machineries. The post-translational changes of the STING protein, along with the regulatory machinery of the secret routes, limit the onset, strength and sustention of STING signal. STING experiences a conformational shift and relocates with TBK1 from the ER to perinuclear vesicles containing transcription factors, provoking the transcription activity of IRF3/IFN-I and NF-κB pathways, as well as to initiate a number of cellular processes that have been shown to alter the immune landscape in cancer, such as autophagy, NLRP3 inflammasome, ER stress, and cell death. STING signal thus serves as a potent activator for immune mobilization yet also triggers immune-mediated pathology in tissues. Recent advances have established the vital role of STING in immune surveillance as well as tumorigenic process. This review provides an overview of the disparate outcomes of cancer attributed to the actions of pleiotropic and coordinated STING downstream signalosomes, along with the underlying mechanisms of STING function in pathologies, providing therapeutic implications for new approaches in hunt for the next generation of cancer immunotherapy base on STING.

Potential role of cGAS/STING pathway in regulating cancer progression

cGAS-STING signaling pathway in gastrointestinal inflammatory disease and cancers

Cell-to-cell communications of cGAS-STING pathway in tumor immune microenvironment.

The cGAS/STING Pathway: A Novel Target for Cancer Therapy

Cellular functions of cGAS-STING signaling

The Cytosolic DNA-Sensing cGAS-STING Pathway in Cancer

Regulation of cGAS-STING signalling in cancer: Approach for combination therapy

Research Advances in How the cGAS-STING Pathway Controls the Cellular Inflammatory Response

Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies

Expanding the Role of STING in Cellular Homeostasis and Transformation

Immune Regulation of the cGAS-STING Signaling Pathway in the Tumor Microenvironment and Its Clinical Application

The multiple faces of cGAS-STING in antitumor immunity: prospects and challenges

Advances in the Prerequisite and Consequence of STING Downstream Signalosomes

Significance of the cGAS-STING Pathway in Health and Disease

cGAMP-activated cGAS–STING signaling: its bacterial origins and evolutionary adaptation by metazoans

At the Crossroads of the cGAS-cGAMP-STING Pathway and the DNA Damage Response: Implications for Cancer Progression and Treatment

The cGAS/STING signaling pathway: a cross-talk of infection, senescence and tumors

Role of micronucleus-activated cGAS-STING signaling in antitumor immunity

DNA sensing in cancer: Pro-tumour and anti-tumour functions of cGAS-STING signalling

Epigenetic regulation of cGAS and STING expression in cancer

New Frontiers on Intracellular cGAS Activation: Molecular Mechanisms, Cellular Signaling, and Therapeutic Strategies